The Food and Drug Administration accepted Novo Nordisk’s marketing application for an oral version of its weight-loss drug Wegovy and will decide in the fourth quarter, the Danis ...

In 2023, experts decided against adding obesity drugs to the World Health Organisation's essential medicines list.